Ananda Immunotherapies is a clinical-stage biotech, still in stealth, and a spin-out from Duke-NUS / Singhealth in Singapore. Ananda's science and therapeutic candidates are focused on immune tolerance: specifically, cell-based approaches to reverse autoimmunity and restore a healthy balance to the immune system. This is in contrast to the current predominant approach of immune suppression to treat autoimmunity.